The Potential of Digital Twins for Pediatric Rare Diseases

Area of Science:

• Biomedical Engineering
• Computational Biology
• Pediatric Medicine

Background:

• Rare diseases impact over 300 million globally, with 75% appearing in childhood.
• Diagnosis delays and lack of treatments are significant issues in pediatric rare diseases.
• Ethical and developmental complexities hinder research in this field.

Purpose of the Study:

• To explore the potential of Digital Twins (DTs) in advancing precision medicine for pediatric rare diseases.
• To discuss the integration of DTs in diagnostics, therapy, and clinical trials.
• To examine associated challenges and regulatory considerations.

Main Methods:

• Utilizing mechanistic and AI/ML models to create virtual patient representations (Digital Twins).
• Applying DTs for hypothesis testing, precision diagnostics, and personalized therapy development.
• Conducting in silico trials using DTs for pediatric rare disease research.

Main Results:

• Digital Twins enable hypothesis testing and precision diagnostics in pediatric rare diseases.
• DTs facilitate personalized therapy development and in silico clinical trials.
• The technology offers a platform for exploring complex rare disease mechanisms.

Conclusions:

• Digital Twins show significant promise for advancing precision medicine in pediatric rare diseases.
• Addressing data, ethical, legal, and regulatory challenges is crucial for DT implementation.
• DTs can revolutionize research and treatment strategies for rare pediatric conditions.